Literature DB >> 3430343

Statistical evaluation of nonisothermal prediction of drug stability.

S Yoshioka1, Y Aso, M Uchiyama.   

Abstract

Nonisothermal prediction of drug stability based on direct nonlinear estimation of the shelf-life was compared with the isothermal approach. The reliability of the statistics for the estimates of the shelf-life (the time period required for a drug to degrade to 90% remaining at 25 degrees C) and activation energy obtained by the two methods was evaluated by the Monte Carlo method of computer simulations. The accuracy and precision of the estimates obtained by the nonisothermal method depended largely on the experimental conditions, such as experimental periods, sampling time, and temperature rise programs. The uncertainty of the estimates was determined mainly by the extents of drug degradation and temperature change achieved during the experiment. The nonisothermal method needed suitable experimental designs and precise assay methods of drug contents to provide reliable parameter estimates.

Mesh:

Year:  1987        PMID: 3430343     DOI: 10.1002/jps.2600761009

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.

Authors:  Alexis Oliva; Matías Llabrés; José B Fariña
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

2.  Nonisothermal stability assessment of stable pharmaceuticals: testing of a clindamycin phosphate formulation.

Authors:  J E Kipp; J J Hlavaty
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

3.  Isothermal and nonisothermal kinetics in the stability prediction of vitamin A preparations.

Authors:  S Yoshioka; Y Aso; Y Takeda
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

4.  A bayesian approach to Arrhenius prediction of shelf-life.

Authors:  X Y Su; A Li Wan Po; S Yoshioka
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.